Table 1.
Clinicopathologic characteristics of 207 pancreatic ductal adenocarcinoma patients undergoing surgery
| Parameter |
No. of patients |
|||
| Simultaneous resections (Group A) | Palliative surgical bypass (Group B) | Total (Group A + Group B) | Pancreatectomy alone (Group C) | |
| n = 30 | n = 39 | n = 69 | n = 138 | |
| Mean age ± SD, yr | 62.2 ± 10.0 | 63.0 ± 10.4 | 62.6 ± 10.1 | 58.8 ± 10.6 |
| Sex (Female) | 10 | 12 | 22 | 45 |
| ASA | ||||
| I | 11 | 10 | 21 | 37 |
| II | 19 | 27 | 46 | 97 |
| III | 0 | 2 | 2 | 4 |
| IV | 0 | 0 | 0 | 0 |
| Primary tumor location | ||||
| Head/neck | 15 | 38 | 53 | 106 |
| Body/tail | 15 | 1 | 16 | 32 |
| Median primary tumor size [IQR], cm | 4.0 (2.5-5.0) | - | - | 3.0 (2.0-3.5) |
| Pathology (PDAC) | 30 | 39 | 69 | 138 |
| TNM stage | ||||
| I | 0 | 0 | 0 | 22 |
| IIA | 0 | 0 | 0 | 22 |
| IIB | 0 | 0 | 0 | 94 |
| III | 0 | 0 | 0 | 0 |
| IV | 30 | 39 | 69 | 0 |
| Primary tumor differentiation | ||||
| Well/moderate | 13 | - | - | 71 |
| Poor | 17 | - | - | 67 |
| Ki67 [IQR], % | 20 (8-30) | - | - | 30 (15-50) |
| Venous invasion | 3 | 19 | 22 | 37 |
| Lymph node invasion | 14 | - | - | 82 |
| Hepatic metastasis | 30 | 39 | 69 | 0 |
| Surgery for primary tumor | ||||
| Total pancreatectomy | 1 | 0 | 1 | 5 |
| Pancreaticoduodenectomy | 11 | 0 | 11 | 95 |
| Distal pancreatectomy | 18 | 0 | 18 | 38 |
| Palliative bypass | 0 | 39 | 39 | 0 |